Losses
-€648,555 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
SMARTVALUE
Lifetime
15 annual accounts with figures on one time axispeak €57.2m (2024)
€49.0m▼ 14.2%
lowest -€596,760 (2020)
-€224,077▲ €200,402
peak €4.0m (2018)
€2.4m▼ 8.4%
€12.8m▼ 11.3%
peak 155.4 FTE (2022)
149 FTE▲ 1.4%
Board9 names since 2021
5 directorsGJ Lifescience management SRL and 4 others
Owners2 names in the annual accounts
100%NEWPHARMA GROUP
Documentsfilings and deeds
25-09-202536 days before the deadline
2025financial year
Turnover from €57.2m to €49.0mLoss of €224,077Merger: absorbed by Newpharma Group 20-11Merger proposal: to be absorbed by Newpharma Group 04-094 directors appointed 12-02Investments €4.8m
Key points
from the 2025 annual accounts, the last ones filedDebts
€12.8m 84% of the balance sheet
Suppliers 51%Taxes and wages 9%Other 40%
Of this, €12.7m falls due within a year.
Investments
€4.8m 2.2 × depreciation
Green is investment, beige is depreciation.
Staff
165 employees on 31-03-2025
In 2025, 46 people joined and 19 left. On top of that, 81 agency workers worked there on average.
Payment terms
60 days to suppliers
SMARTVALUE pays its suppliers 4 days earlier than in 2024. Customers pay 24 days earlier.
Filings
15 annual accounts since 2010
Two of the last ten came late. The 2015 accounts came latest: 31 days after the end of the period.
No score
Board and ownership
GL
GJ Lifescience management SRL
Director, since 14-07-2021
Shares in 2 companies, SMARTVALUE SERVICES and NEWPHARMA
Board & ownershipRecent changes
Merger: absorbed by Newpharma Group
Gazette deed
Merger proposal: to be absorbed by Newpharma Group
Newpharma Group holds all the shares · SUKHINO holds all the shares · Gazette deed
4 directors appointed
CASTELEIN, Kris Roger; GOETHAERT, Stefan Annie Willy Maria; VANDAMME, Stefaan Walter Alphons and WILLEMYNS, Jo Paul Maria Agnès Maurits · Legal-form conversion: from private limited company to public limited company · Capital of €61,500, 250 shares · Gazette deed
Appointment: EY Réviseurs d'Entreprises (statutory auditor)
Permanent representative: Jourquin Gilles · Gazette deed
Official details
Source: KBO- Status
- Absorbed by Newpharma Groupmerger by absorption, October 2025
- Activity
- “1) La société a pour objet toutes opérations relatives à la conception, au développement…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 March
- Peppol
- Not found in the Peppol Directory
Annual accounts to 31-03-2025
- €15.2m▼ 11.2%
- Employeeson 31-03-2025
- 165▲ 19.6%
- Filing
- Filed on 25-09-2025
Insights on SMARTVALUE
SMARTVALUE reached its highest turnover since 2017 in 2024: €57.2m. A year later it was €49.0m.
Equity fell from €4.0m in 2018 to €2.4m in 2025, while debts rose from €4.4m to €12.8m.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SMARTVALUE
- What is the company number of SMARTVALUE?
- The company number of SMARTVALUE is 0821.903.467. The VAT number is the same number with BE in front: BE 0821.903.467.
- What is the legal form of SMARTVALUE?
- Legal form of SMARTVALUE: SA.
- Is SMARTVALUE still active?
- No. SMARTVALUE is inactive in the KBO register.Company details
- How many employees did SMARTVALUE have?
- SMARTVALUE had an average of 149 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of SMARTVALUE?
- The turnover of SMARTVALUE was €49.0m in financial year 2025, according to the filed annual accounts.
- Is SMARTVALUE profitable?
- In financial year 2025, SMARTVALUE made a loss of €224,077.
- Where can I find the annual accounts of SMARTVALUE?
- SMARTVALUE filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.